Literature DB >> 17929794

Poorly soluble marketed drugs display solvation limited solubility.

Christel A S Bergström1, Carola M Wassvik, Kajsa Johansson, Ina Hubatsch.   

Abstract

We determined the intrinsic aqueous solubility of 15 poorly soluble drugs with solubilities ranging from 2.9 nM to 1.1 microM. We then analyzed the data from a physicochemical perspective, using experimentally determined solid-state properties and easily interpretable two-dimensional molecular descriptors, to better understand the factors underlying poor solubility. The analysis shows that poorly soluble drugs that have reached the market are solubility limited by solvation rather than by their solid state.

Mesh:

Substances:

Year:  2007        PMID: 17929794     DOI: 10.1021/jm0706416

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

1.  Cocrystal Solubility Product Prediction Using an in combo Model and Simulations to Improve Design of Experiments.

Authors:  Alex Avdeef
Journal:  Pharm Res       Date:  2018-02-02       Impact factor: 4.200

Review 2.  Orally Administered Drug Solubility-Enhancing Formulations: Lesson Learnt from Optimum Solubility-Permeability Balance.

Authors:  Bhakti Mahendra Pawar; Syed Nazrin Ruhina Rahman; Datta Maroti Pawde; Abhinab Goswami; Tamilvanan Shunmugaperumal
Journal:  AAPS PharmSciTech       Date:  2021-02-02       Impact factor: 3.246

3.  Studies on tolfenamic acid-chitosan intermolecular interactions: effect of pH, polymer concentration and molecular weight.

Authors:  Sofia Ahmed; Muhammad Ali Sheraz; Ihtesham Ur Rehman
Journal:  AAPS PharmSciTech       Date:  2013-04-27       Impact factor: 3.246

4.  Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents.

Authors:  Rui Shi; Bin Wang; Giovanni Stelitano; Xiaomei Wu; Yuanyuan Shan; Yue Wu; Xin Wang; Laurent R Chiarelli; Yu Lu; Chunhua Qiao
Journal:  ACS Med Chem Lett       Date:  2022-03-10       Impact factor: 4.345

Review 5.  Simulation Models for Prediction of Bioavailability of Medicinal Drugs-the Interface Between Experiment and Computation.

Authors:  Mahmoud E Soliman; Adeniyi T Adewumi; Oluwole B Akawa; Temitayo I Subair; Felix O Okunlola; Oluwayimika E Akinsuku; Shahzeb Khan
Journal:  AAPS PharmSciTech       Date:  2022-03-15       Impact factor: 3.246

6.  Discovery of O-Alkylamino Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents.

Authors:  Haijun Chen; Zhengduo Yang; Chunyong Ding; Lili Chu; Yusong Zhang; Kristin Terry; Huiling Liu; Qiang Shen; Jia Zhou
Journal:  ACS Med Chem Lett       Date:  2013-01-15       Impact factor: 4.345

7.  Computational prediction of drug solubility in lipid based formulation excipients.

Authors:  Linda C Persson; Christopher J H Porter; William N Charman; Christel A S Bergström
Journal:  Pharm Res       Date:  2013-06-15       Impact factor: 4.200

8.  Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations.

Authors:  Hywel D Williams; Philip Sassene; Karen Kleberg; Marilyn Calderone; Annabel Igonin; Eduardo Jule; Jan Vertommen; Ross Blundell; Hassan Benameur; Anette Müllertz; Colin W Pouton; Christopher J H Porter
Journal:  Pharm Res       Date:  2013-05-10       Impact factor: 4.200

9.  Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q₁₀ as naked nanocrystals.

Authors:  Jiao Sun; Fan Wang; Yue Sui; Zhennan She; Wenjun Zhai; Chunling Wang; Yihui Deng
Journal:  Int J Nanomedicine       Date:  2012-11-12

10.  Solvent free fabrication of micro and nanostructured drug coatings by thermal evaporation for controlled release and increased effects.

Authors:  Eman S Zarie; Viktor Kaidas; Dawit Gedamu; Yogendra K Mishra; Rainer Adelung; Franz H Furkert; Regina Scherließ; Hartwig Steckel; Birte Groessner-Schreiber
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.